COLUMN GROUP II, LP's Net Worth
Estimate Recalculated Nov 5, 2024 07:08PM EST
Who is COLUMN GROUP II, LP
COLUMN GROUP II, LP has an estimated net worth of $69.4 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., NGM BIOPHARMACEUTICALS INC, Gritstone Oncology, Inc., RAPT Therapeutics, Inc., Nurix Therapeutics, Inc., Arcus Biosciences, Inc., Oric Pharmaceuticals, Inc., and eFFECTOR Therapeutics, Inc..
SEC CIK
COLUMN GROUP II, LP's CIK is 0001600420
Past Insider Trading and Trends
2019 was COLUMN GROUP II, LP's most active year for acquiring shares with 7 total transactions. COLUMN GROUP II, LP's most active month to acquire stocks was the month of October. 2018 was COLUMN GROUP II, LP's most active year for disposing of shares, totalling 6 transactions. COLUMN GROUP II, LP's most active month to dispose stocks was the month of October. 2019 saw COLUMN GROUP II, LP paying a total of $7,500,000.00 for 6,727,151 shares, this is the most they've acquired in one year. In 2020 COLUMN GROUP II, LP cashed out on 5,839,835 shares for a total of $31,011,178.50, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
